• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: RESHAPE LIFESCIENCES LAP-BAND SYSTEM; ADJUSTABLE GASTRIC BAND

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

RESHAPE LIFESCIENCES LAP-BAND SYSTEM; ADJUSTABLE GASTRIC BAND Back to Search Results
Device Problems Device Slipped (1584); Insufficient Information (3190)
Patient Problems Erosion (1750); Dysphagia/ Odynophagia (1815); Pain (1994); Perforation (2001); Weight Changes (2607); Gastrointestinal Regurgitation (4477)
Event Date 12/17/2018
Event Type  Injury  
Manufacturer Narrative
Investigation is ongoing, and as additional information becomes available, a supplemental report will be made.At this time, the reported issue will be tracked and trended.During the study period, 211 patients underwent lagb removal (87.7% female).Most bands were inserted out of the province where the explant care was provided.Reasons for band removal included dysphagia, band slip and weight recidivism.Fifty-nine patients (28%) underwent revision surgery at a mean of 12.8 ± 9.3 (range 0-55) months after lagb removal.Mean age was 47 ± 9.7 (range 26-63) years, and mean pre-lagb weight was 131.0 ± 30.0 kg.Following lagb, the mean weight decreased to 120.5 ± 26.4 kg, but most regained weight after removal to a mean prerevision weight of 125.1 ± 27.0 kg.The lowest mean weight was achieved 12 months after revision surgery (98.7 ± 30.2 kg).The mean percent total weight loss was not significantly different after revision laparoscopic roux-eny gastric bypass compared with revision laparoscopic sleeve gastrectomy (22.8 ± 9.6% v.17.5 ± 6.5%, p = 0.179).The overall revision surgery 30-day complication rate was 18.6% and increased to 23.7% long-term.No deaths occurred.D6b: study examined outcomes for bands explanted between january 2008 and december 2016, but didn't identify exact dates for the explanted devices.H6: medical device problem code: literature states "port problems" as a reason for device explant.Using insufficient information code until more information becomes available.
 
Event Description
Literature review performed: the fate of laparoscopic adjustable gastric band removal.Vanessa falk, md(1), caroline sheppard, phd(2), aliyah kanji, md(1)(2), daniel birch, md(1)(2), shazeer karmali, md, mph(1) (2), christopher de gara, mb, ms(1)(2).1 - division of general surgery, university of alberta, edmonton, alta.2 - the centre for advancement of minimally invasive surgery, royal alexandra hospital, edmonton, alta.Canandian journal of surgery, vol.62, no.5, october 2019.This published article describes a single-center retrospective review of patients who underwent lagb explants between january 2008 and december 2016.A subset of patients who underwent revision surgery was then analyzed for patient demographics, weight, body mass index and postoperative complications.During the study period, 211 patients underwent lagb removal (87.7% female).Most bands were inserted out of province.Reasons for band removal included dysphagia, band slip and weight recidivism.Accepted for publication: 17dec2018.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LAP-BAND SYSTEM
Type of Device
ADJUSTABLE GASTRIC BAND
Manufacturer (Section D)
RESHAPE LIFESCIENCES
1001 calle amanecer
san clemente CA 92673
Manufacturer Contact
jazmin quiroz
1001 calle amanener
san clemente, CA 92673
8779377374
MDR Report Key16993482
MDR Text Key315853739
Report Number3013508647-2023-00371
Device Sequence Number1
Product Code LTI
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
P000008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial
Report Date 05/24/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/24/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/25/2023
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Other;
Patient Age47 YR
Patient SexFemale
Patient Weight125 KG
-
-